{"disease":{"id":"fungal-blepharitis","name":"Fungal Blepharitis","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"natacyn","indication_name":"Fungal Blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"NATACYN®","company_name":"IVIEW Therapeutics Inc.","drug_phase":"marketed","molecular_target":"","drug_class":"Polyene Antimicrobial","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"natamycin","indication_name":"Fungal Blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Natacyn","generic_name":"NATAMYCIN","company_name":"Harrow Health","drug_phase":"marketed","molecular_target":"","drug_class":"Polyene Antimicrobial [EPC]","quality_score":10,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}